‘Right to Try’ and Proving and Disproving Medical Marijuana Claims by the FDA

Getty Recent statements from the Federal Drug Administration Commissioner suggest that the agency may be considering the legitimacy of medical marijuana claims, years after legalization of the herb for medicinal purposes has taken hold in over half of the country. Most specifically, the concern revolves around claims that cannabis has anti-tumor effects that can cause cancerous tumors to shrink. “I see people who are developing products who are making claims that marijuana has antitumor effects in the setting of cancer,” FDA Commissioner Scott Gottlieb said at a hearing before Congress on a separate matter. “It’s a much broader question...

Read More